Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia

Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia

We studied the efficacy of naftopidil (50 mg/day) on nocturia associated with benign prostatic hyperplasia in 35 patients (62-80 years old). The patients had BPH > 20 ml, nocturia, more than 3 times, international prostate symptom score (IPSS) > 7, quality of life score (QOL) < 1, and maxim...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 49(2003), 8 vom: 07. Aug., Seite 445-9
1. Verfasser: Sugino, Yoshio (VerfasserIn)
Weitere Verfasser: Fukuzawa, Shigeki, Takeuchi, Hideo, Taki, Youji, Hashimura, Takayuki, Soeda, Tomoki, Araki, Isao
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2003
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial English Abstract Journal Article Multicenter Study Adrenergic alpha-Antagonists Naphthalenes Piperazines naftopidil R9PHW59SFN